A new breast cancer drug is being tested in Manchester, that could be a lifeline to women with the most aggressive form of the disease.
The drug, known as T-DM1, is designed to slow the progress of The treatment increases the survival time of some patients by almost six months.
It also reduces side effects such as hair loss, and gives sufferers a better quality of life
More top news
The former England captain said he is "shocked and deeply saddened" by the child abuse scandal surrounding the game.
Transport Secretary Chris Grayling reportedly wants the publicly-owned firm to share responsibility for running tracks with private firms.
A teenager from Manchester has been jailed for more than four years after he was found with a "paedophile manual".